From The Labs Archives - Page 10 of 102 - Baylor College of Medicine Blog Network

Unexpected findings provide a deeper understanding of Myotonic Dystrophy Type 1

October 29, 2024 DM1, DMPK, heart problems, muscle wasting, Research, SCN5A

While the Baylor team was testing a strategy to improve heart defects associated with DM1, they uncovered an unexpected new insight into the condition.

From The Labs

ClinGen creates a robust, open-access platform to define the clinical relevance of genes and variants

October 24, 2024 CLinGen, clinical relevance of genes, gene curation, Research

ClinGen can be used to build evidence-based genetic testing panels, resolve discrepancies in variant classification and guide disclosure of genomic findings to patients.

From The Labs

Congratulations, Dr. Maria E. Bottazzi and Dr. Teresa A. Davis, Baylor’s newly elected members to the National Academy of Medicine!

October 22, 2024 Awards, National Academy of Medicine;, Nutrition, Research, Vaccines

Election to the National Academy of Medicine is considered one of the highest honors that recognizes individuals for their outstanding professional achievement and commitment to service in health and medicine.

From The Labs

A potentially simpler test and novel therapy for endometriosis

October 15, 2024 4-hydroxyindole, diagnostic test, endometriosis, gut microbiome, IBD, Research, treatment

This is the first report of a unique metabolite profile linked to human endometriosis, bringing us closer to better ways to manage the condition.

From The Labs

Reviving immune responsiveness after tuberculosis

October 10, 2024 epigenetics, everolimus, immune weakness, Research, tricarboxylic acid cycle, tuberculosis

The findings could reduce the illness and mortality that occur after TB has been successfully treated.

From The Labs

DAPK3 emerges as a new regulator of migration of triple-negative breast cancer cells

October 8, 2024 cancer cell migration, DAPK3, desmoplakin, LUZP1, Research, triple-negative breast cancer

The researchers’ next steps include studying how DAPK3 promotes TNBC migration and assess its potential value as a therapeutic target.

From The Labs

New mouse model mimics progression of Parkinson’s disease

October 3, 2024 disease model, G51D mutation, Parkinson's Disease, Research, SNCA gene

This model can help identify new disease biomarkers and test therapies that could alter its progression, maybe even prevent the condition.

From The Labs

Center for NextGen Therapeutics helps match researchers to molecules

October 1, 2024 BCM Centers, drug discovery, multispecific drugs, NextGen Therapeutics, Research

Dr. Jin Wang explains what the new Center for NextGen Therapeutics has to offer to researchers at Baylor College of Medicine, across the Texas Medical Center and beyond.